55513-0078 Imlygic - CanMED: NDC

Product NDC:

55513-0078

Brand Name:

Imlygic

Generic Name:

Talimogene Laherparepvec

Dosage Form Name:

INJECTION, SUSPENSION

Administration Route:

Intralesional

Substances:

Name: Talimogene Laherparepvec

Strength: 1000000.0

Unit: [PFU]/mL

Packages:

Code: 55513-0078-01

Description: 1 VIAL in 1 CARTON (55513-078-01) / 1 mL in 1 VIAL

Effective Date: Nov. 2, 2015

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Therapeutic Cancer Vaccine

Minor Class:

Oncolytic Virus

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox